Methylprednisolone and Multaq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Multaq (dronedarone hydrochloride). Common drug interactions include malaise among females and sciatica among males.
The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Multaq. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Methylprednisolone?
Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.
What is Multaq?
Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.
14 people who take Methylprednisolone and Multaq together, and have interactions are studied.

What are the common drug interactions of Methylprednisolone and Multaq, by gender? *:
female:
- Malaise (a feeling of general discomfort or uneasiness)
- Multiple fractures
- Osteoporosis (bones weak and more likely to break)
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
- Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
- Ankle fracture
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Bone marrow disorder
- Bone pain
- Brain abscess
male:
- Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
- Dyspepsia (indigestion)
- Blood creatinine increased
- Heart rate decreased
- Malaise (a feeling of general discomfort or uneasiness)
- Oedema peripheral (superficial swelling)
- Agitation (state of anxiety or nervous excitement)
- Brain death
- Cardiac fibrillation (uncontrolled muscle contraction of heart)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
What are the common drug interactions of Methylprednisolone and Multaq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Brain abscess
40-49:
- Ankle fracture
- Bone marrow disorder
- Chest pain
- Cough
- Joint dislocation (a joint position is changed from normal position)
- Malaise (a feeling of general discomfort or uneasiness)
- Multiple fractures
- Osteoporosis (bones weak and more likely to break)
- Pericarditis (inflammation of the pericardium)
- Weight increased
50-59:
- Dyspepsia (indigestion)
- Vomiting
- Cardiac failure chronic
- Liver injury
- Abdominal distension
- Abdominal pain upper
- Asthenia (weakness)
- Blood creatinine increased
- Heart rate decreased
- Malaise (a feeling of general discomfort or uneasiness)
60+:
- Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
- Renal failure acute (rapid kidney dysfunction)
- Septic shock (shock due to blood infection)
- Ventricular fibrillation (abnormally irregular heart rhythm)
- Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Contusion (a type of hematoma of tissue in which capillaries)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Haemoglobin decreased
What are the existing conditions these people have? *
- Asthma: 3 people, 21.43%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
- High Blood Pressure: 2 people, 14.29%
- Pain: 2 people, 14.29%
- Muscle Spasms (muscle contraction): 2 people, 14.29%
- Gout (uric acid crystals building up in the body): 2 people, 14.29%
- Tinnitus (a ringing in the ears): 1 person, 7.14%
- Blood Test Abnormal: 1 person, 7.14%
- Cardiac Disorder: 1 person, 7.14%
- Cardiac Failure Congestive: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Methylprednisolone and Multaq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylprednisolone (59,645 reports)
- Multaq (11,053 reports)
Browse all drug interactions of Methylprednisolone and Multaq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylprednisolone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Multaq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylprednisolone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Multaq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methylprednisolone and dronedarone hydrochloride (the active ingredients of Methylprednisolone and Multaq, respectively), and Methylprednisolone and Multaq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metronidazole cause Photophobia? - 4 seconds ago
- Drug interactions of Zyvox and Moxifloxacin - 21 seconds ago
- Wound and Memory Loss - 22 seconds ago
- Could Ibu cause Uveitis? - 30 seconds ago
- Drug interactions of Combivent Respimat and Armodafinil - 34 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Xgeva - 37 seconds ago
- Could Zelnorm cause Deep Venous Thrombosis? - 51 seconds ago
- Could Tramadol cause Aphagia? - a minute ago
- Could Dysport cause Nausea And Vomiting? - a minute ago
- Weight Loss and Groin Pain - a minute ago